Exploring Bisphosphonates As Antitumor Agents In Breast Cancer
If you are looking for information about Bisphosphonates As Antitumor Agents In Breast Cancer, you have come to the right place.
- Adam M. Brufsky, MD, PhD, professor of medicine, associate chief, Division of Hematology/Oncology, University of Pittsburgh, ...
- Julie R. Gralow, MD, director,
- http://www.medpagetoday.com SAN ANTONIO -- Women taking the osteoporosis drug zoledronic acid had a 30% to 35% lower ...
- In this segment, Sara Hurvitz, MD; Hope Rugo, MD; Dialecti Voudouris, MD; and Eleftherios Mamounas, MD, examine the use of ...
- Adam M. Brufsky, MD, PhD, professor of medicine, associate chief, Division of Hematology/Oncology, University of Pittsburgh, ...
In-Depth Information on Bisphosphonates As Antitumor Agents In Breast Cancer
Dr. Hope S. Rugo, associate editor of The Oncology Report, discusses the use of Debu Tripathy, MD, co-leader, Women's Debu Tripathy, MD, co-leader, Women's Dr. Clay Couvillon explains how a class of
Julie R. Gralow, MD, director,
We hope this detailed breakdown of Bisphosphonates As Antitumor Agents In Breast Cancer was helpful.
